Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals

Published: Tuesday, November 26, 2013
Last Updated: Monday, November 25, 2013
Bookmark and Share
This year sees strong growth in APIs, biopharma, natural extracts, packaging and finished dosage with a highlight on innovation.

CPhI Worldwide celebrates the closing of its most successful show to date with pre-audit figures estimating more than 34,000 attendees and 2,200 exhibitors.

Held in Frankfurt, the show hosted senior-level decision makers and key players from 140+ countries representing every step of the pharmaceutical supply chain from drug discovery to finished dosage.

On Monday, CPhI Conferences hosted the Pre-Connect with 6 modules on themes including drug delivery systems and biosimilars. The conference featured senior executives and influential industry speakers from Bayer, Novartis and Wockhardt, who leveraged their expertise and insight to educate the industry.

Throughout the week, free content was available in the exhibition with sessions covering Ingredients, Contract Services, Packaging, Animal Health, Biopharma and Natural Extracts, Innovation Tours on biopharma and packaging, and Lunch Briefings on emerging markets of India and Brazil.

With 4 different exhibitions in one (CPhI, P-MEC, InnoPack and ICSE) the event has become the world’s melting pot and key point of the year to complete new deals, see innovative technologies and meet potential partners- attendees say it’s invaluable to the industry.

This year’s event held a record of 17 global pavilions to highlight different countries from each continent- including China, India, USA and Brazil amongst others.

The winners of the 2013 CPhI Pharma Awards were announced, honouring innovation across three categories (Best Innovation in Formulation, Packaging and Process Development) which went to Camurus, E-Pharma Trento and API Corporation, respectively.

Another major addition to this year’s show was the introduction of CPhI Pharma Evolution- a new community website launched in February to help professionals from the pharma industry to share advice from their peers on best-practices and regulatory changes across the pharmaceutical ingredient and contract manufacturing space.

The site features a wealth of stories covering the huge amounts of activity across all four days of the show, including news on all the major initiatives and company news announced. For more information, please visit:

CPhI Worldwide and CPhI Pharma Evolution were pleased to release its first Annual Report during the event. Written by a panel of industry experts, the report highlighted key trends including QbD, PAT and six sigma in a series of forward looking articles.

Chris Kilbee, Group Director of CPhI, commented: “This year’s event has been a great success with exhibitors reporting quality meetings and promising business opportunities coming out of the event. We’re pleased to expand our content offering this year with seminars, innovation tours and the release of the first Annual Report. As the pharmaceutical market continues to grow and expand, CPhI will adapt and evolve to deliver industry insights and continue to provide the best platform for developing contacts as the event returns to Paris for its 25th edition from 7–9 October 2014.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

CPhI Report Highlights Acquisitions of Niche Technologies
Medium term prospects for contract services remain positive (both developed and emerging markets), despite fragmented biosimilar regulation and GDUFA fees.
Thursday, October 15, 2015
#CPhIChat Returns to CPhI Worldwide for the Second Successive Year
Pharma community is encouraged to lend their views on key industry issues.
Saturday, October 10, 2015
CPhI Experts Predict Continuous Manufacturing for All Within 10-years
Brian Carlin emphasizes need to build flexibility into design to manage impact of raw material variability through product lifecycle.
Thursday, October 01, 2015
CPhI China Report Predicts Domestic Growth to Outpace Exports
Emerging cities, biopharmaceuticals and APIs to drive future expansion.
Friday, August 14, 2015
CPhI & P-MEC China Closes as the Chinese Domestic Market Continues to Expand
International companies looking to gain a foothold in this lucrative and gentrifying pharma economy.
Tuesday, August 11, 2015
CPhI Korea Opens as South Korea Emerges as Global Leader in Biosimilar Trials
Government’s R&D strategy and “Pharma 2020 Vision” to see country as drug development leader.
Monday, July 27, 2015
CPhI Announces USA Market Report at InformEx
Country report to contain contrasting insights into the American pharma economy from European and domestic perspectives.
Wednesday, January 22, 2014
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Kilbee responsible for driving the portfolio globally including increased emphasis on digital and content.
Monday, January 13, 2014
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Growth in the World’s second largest pharma region facilitated by innovation and loosened regulatory guidelines.
Monday, December 30, 2013
John van der Valk Appointed MD of UBM Live Amsterdam
Valk responsible for overseeing the company’s flagship brand CPhI.
Monday, December 23, 2013
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand
Free online registration to attend CPhI and P-MEC India is now closed.
Tuesday, December 03, 2013
India Sets Ambitious Pharma Export Growth Targets
Indian generics exports growing at 24% per annum.
Monday, October 21, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos